Innovative medicines supported as rebate rate falls by a third
By Liz Wells 10 December 2025
Patients across the UK will benefit from innovative and life-changing treatments following a cut in rebate costs for pharmaceutical companies.
Strategic Director of Adult Social Care and Health
circa £130,000 p.a.
Tameside, Greater Manchestercirca £130,000 p.a.
Most Read News
- AI regulatory framework programme for medical devices secures funding
- SEND reform won't reduce system pressures. It will redistribute them.
- Councils increase debt to fund higher social care costs
- North London measles cases rising outside Enfield
- People in mental health crisis at risk in emergency departments
Strategic Director of Adult Social Care and Health
circa £130,000 p.a.
Tameside, Greater Manchestercirca £130,000 p.a.
Most Read News
- AI regulatory framework programme for medical devices secures funding
- SEND reform won't reduce system pressures. It will redistribute them.
- Councils increase debt to fund higher social care costs
- North London measles cases rising outside Enfield
- People in mental health crisis at risk in emergency departments
©2026 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
